Google Alert - lose weight

	lose weight As-it-happens update ⋅ June 7, 2026
	NEWS
	Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss - YouTube YouTube At the 2026 Scientific Sessions of the American Diabetes Association, John Buse, MD, PhD, discusses new phase 2b data from the VESPER-1 open-label ... Flag as irrelevant
	A new wave of weight-loss therapies aims to be better than today's GLP-1s - MarketWatch MarketWatch Retatrutide is one of those drugs. It helped people lose a massive amount of weight in clinical trials. It also improved sleep apnea and knee ... Flag as irrelevant
	Woman Bullied for Her Weight Says Former Bullies Now Want Weight-Loss Advice - People.com People.com A woman who was bullied about her weight in high school is now getting messages asking for weight-loss tips from former classmates · Olivia Bennett, 29 ... Flag as irrelevant
	A new wave of weight-loss therapies aims to be better than today's GLP-1s | Morningstar Morningstar One of the most anticipated new weight-loss drugs also helped people struggling with common obesity-related conditions like sleep apnea. The drug is ... Flag as irrelevant
	Popular weight loss and diabetes drugs show no biological link to mental illness - PsyPost PsyPost Despite troubling reports of anxiety and depression among users of new weight loss and diabetes medications, a comprehensive genetic and clinical ... Flag as irrelevant
	Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee ... PR Newswire In TRIUMPH-1, participants on retatrutide 12 mg lost an average of 70.3 lbs (28.3%) over 80 weeks, with 65.3% achieving a BMI below 30, ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback